Annette Juul Vangsted

Annette Juul Vangsted

Clinical Associate Professor

Member of:

  • Internal Medicine: Haematology


Publication year:
All
21 - 30 out of 58Page size: 10
  1. 2020
  2. Published

    Clinically-suspected cast nephropathy: A retrospective, national, real-world study

    Szabo, A. G., Thorsen, Jonathan Jan Ilve, Iversen, K. F., Hansen, C. T., Teodorescu, E. M., Pedersen, S. B., Flaeng, S. B., Strandholdt, C., Frederiksen, M., Vase, M. Ø., Frølund, U. C., Krustrup, D., Plesner, T. & Vangsted, Annette Juul, 2020, In: American Journal of Hematology. 95, 11, p. 1352-1360 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Human P2X7 Receptor Causes Cycle Arrest in RPMI-8226 Myeloma Cells to Alter the Interaction with Osteoblasts and Osteoclasts

    Agrawal, A., Kruse, L. S., Vangsted, Annette Juul, Gartland, A. & Jørgensen, Niklas Rye, 2020, In: Cells. 9, 11

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)

    Terpos, E., Engelhardt, M., Cook, G., Gay, F., Mateos, M. V., Ntanasis-Stathopoulos, I., van de Donk, N. W. C. J., Avet-Loiseau, H., Hajek, R., Vangsted, Annette Juul, Ludwig, H., Zweegman, S., Moreau, P., Einsele, H., Boccadoro, M., San Miguel, J., Dimopoulos, M. A. & Sonneveld, P., 2020, In: Leukemia. 34, 8, p. 2000-2011 12 p.

    Research output: Contribution to journal › Review › Research › peer-review

  5. 2019
  6. Published

    Genetic polymorphisms in genes of class switch recombination and multiple myeloma risk and survival: an IMMEnSE study

    Campa, D., Martino, A., Macauda, A., Dudziński, M., Suska, A., Druzd-Sitek, A., Raab, M-S., Moreno, V., Huhn, S., Butrym, A., Sainz, J., Szombath, G., Rymko, M., Marques, H., Lesueur, F., Vangsted, A. J., Vogel, U., Kruszewski, M., Subocz, E., Buda, G. & 27 others, Iskierka-Jażdżewska, E., Ríos, R., Merz, M., Schöttker, B., Mazur, G., Perrial, E., Martinez-Lopez, J., Butterbach, K., García Sanz, R., Goldschmidt, H., Brenner, H., Jamroziak, K., Reis, R. M., Kadar, K., Dumontet, C., Wątek, M., Haastrup, E. K., Helbig, G., Jurczyszyn, A., Jerez, A., Varkonyi, J., Barington, T., Grzasko, N., Zaucha, J. M., Andersen, V., Zawirska, D. & Canzian, F., Jul 2019, In: Leukemia and Lymphoma. 60, 7, p. 1803-1811 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

    Klausen, T. W., Gregersen, H., Abildgaard, N., Andersen, N. F., Frølund, U. C., Gimsing, P., Helleberg, C. & Vangsted, Annette Juul, Feb 2019, In: Leukemia. 33, 2, p. 546-549 4 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  8. Published

    Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

    PRACTICAL consortium, P. C., 10 Jan 2019, In: Nature Communications. 10, 1, 3 p., 213.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Clarithromycin added to bortezomib-cyclophosphamide-dexamethasone impairs health-related quality of life in multiple myeloma patients

    Nielsen, L. K., Klausen, T. W., Jarden, Mary Ellen, Frederiksen, H., Vangsted, Annette Juul, Do, T., Kristensen, I. B., Frølund, U. C., Andersen, Christen Bertel L, Abildgaard, N. & Gregersen, H., Jan 2019, In: European Journal of Haematology. 102, 1, p. 70-78 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study

    Sørrig, R., Klausen, T. W., Salomo, M., Vangsted, Annette Juul & Gimsing, P., 2019, In: European Journal of Haematology. 102, 2, p. 182-190

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. 2018
  12. Published

    Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma

    Went, M., Sud, A., Försti, A., Halvarsson, B. M., Weinhold, N., Kimber, S., van Duin, M., Thorleifsson, G., Holroyd, A., Johnson, D. C., Li, N., Orlando, G., Law, P. J., Ali, M., Chen, B., Mitchell, J. S., Gudbjartsson, D. F., Kuiper, R., Stephens, O. W., Bertsch, U. & 31 others, Broderick, P., Campo, C., Bandapalli, O. R., Einsele, H., Gregory, W. A., Gullberg, U., Hillengass, J., Hoffmann, P., Jackson, G. H., Jöckel, K. H., Johnsson, E., Kristinsson, S. Y., Mellqvist, U. H., Nahi, H., Easton, D., Pharoah, P., Dunning, A., Peto, J., Canzian, F., Swerdlow, A., Eeles, R. A., Kote-Jarai, Z. S., Muir, K., Pashayan, N., Nickel, J., Nöthen, M. M., Vangsted, Annette Juul, Andersen, N. F., Nilsson, B., Nordestgaard, Børge & The Practical Consortium, T. P. C., 13 Sep 2018, In: Nature Communications. 9, 10 p., 3707.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma

    Gregersen, H., Do, T., Kristensen, I. B., Frølund, U. C., Andersen, N. F., Nielsen, L. K., Andersen, Christen Bertel L, Klausen, T. W., Vangsted, Annette Juul & Abildgaard, N., 2018, In: Experimental Hematology & Oncology. 7, 1, 18.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 Next

ID: 9762536